Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Skystar Bio-Pharmaceutical Co (NASDAQ:SKBI)

1.98
Delayed Data
As of Jul 31
 +0.04 / +2.06%
Today’s Change
1.67
Today|||52-Week Range
5.92
-53.08%
Year-to-Date

Today’s Trading

Previous close1.94
Today’s open1.93
Day’s range1.93 - 2.06
Volume10,176
Average volume (3 months)23,405
Market cap$17.2M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+66.27%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.14%
Revenue growth (last year)+26.49%
P/E ratio1.4
Price/Sales0.64
Price/Book0.14

Competitors

 Today’s
change
Today’s
% change
ECTEEcho Therapeutics In...-0.01-0.61%
CAPNCapnia Inc+0.05+2.34%
DARADARA BioSciences Inc-0.01-1.20%
CBLICleveland Biolabs In...-0.07-1.74%
Data as of 3:59pm ET, 07/31/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$42.5M
Annual profit (last year)$10.5M
Net profit margin24.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Wei Bing Lu
CFO &
Principal Accounting Officer
Bing Mei
Corporate headquarters
Xi'an, Shaanxi

Forecasts